Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain

28 Dec 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to Viral gastroenteritis research and epidemiology

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 38157856
DOI: 10.1016/j.str.2023.11.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domainPMID 38157856Read ↗

Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human antibodySemantic proximity Read ↗

Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognitionSemantic proximity Read ↗

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionSemantic proximity Read ↗

Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodiesSemantic proximity Read ↗

Towards an optimal monoclonal antibody with higher binding affinity to the receptor-binding domain of SARS-CoV-2 spike proteins from different variantsSemantic proximity Read ↗

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodiesSemantic proximity Read ↗

Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016Semantic proximity Read ↗

Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibodySemantic proximity Read ↗

On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2Semantic proximity Read ↗

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike proteinSemantic proximity Read ↗

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike proteinSemantic proximity Read ↗

A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.